AU3632393A - Use of sydnonimines to treat erectile dysfunction - Google Patents
Use of sydnonimines to treat erectile dysfunctionInfo
- Publication number
- AU3632393A AU3632393A AU36323/93A AU3632393A AU3632393A AU 3632393 A AU3632393 A AU 3632393A AU 36323/93 A AU36323/93 A AU 36323/93A AU 3632393 A AU3632393 A AU 3632393A AU 3632393 A AU3632393 A AU 3632393A
- Authority
- AU
- Australia
- Prior art keywords
- sydnonimines
- erectile dysfunction
- treat erectile
- treat
- dysfunction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4209462 | 1992-03-24 | ||
DE19924209462 DE4209462A1 (en) | 1992-03-24 | 1992-03-24 | Treatment of impotence |
DE19924213338 DE4213338A1 (en) | 1992-04-23 | 1992-04-23 | Treatment of impotence |
DE4213338 | 1992-04-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3632393A true AU3632393A (en) | 1993-10-21 |
Family
ID=25913140
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU36323/93A Abandoned AU3632393A (en) | 1992-03-24 | 1993-03-10 | Use of sydnonimines to treat erectile dysfunction |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3632393A (en) |
WO (1) | WO1993018767A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4305881C1 (en) * | 1993-02-26 | 1994-03-03 | Lohmann Therapie Syst Lts | Transdermal therapeutic system for topical and systemic application of active agents - includes cpd(s) from which nitrogen oxide is released by human or animal metabolism or cpds which release nitrogen oxide in organism |
GB2339533A (en) * | 1998-07-14 | 2000-02-02 | James Martin Biggs | Topical pharmaceutical preparations |
EA032064B1 (en) * | 2013-03-15 | 2019-04-30 | Мелиор Фармасьютикалз Ii, Ллс | Method of treating levodopa-induced dyskinesia using sydnocarb |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1496056A (en) * | 1964-06-08 | 1967-09-29 | Takeda Chemical Industries Ltd | New chemical compounds of the sydnonimine type |
DE1695897C3 (en) * | 1966-07-04 | 1979-02-15 | Takeda Chemical Industries Ltd | N-acyl-sydnonimines, their salts, processes for their preparation and medicaments containing these compounds |
DE1670127A1 (en) * | 1966-08-09 | 1970-12-03 | Boehringer Sohn Ingelheim | Process for the preparation of new substituted 3-amino-sydnonimines |
DE3702083A1 (en) * | 1987-01-24 | 1988-08-04 | Cassella Ag | ALLYLMERCAPTOACETYL SYDNONIMINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE |
-
1993
- 1993-03-10 WO PCT/EP1993/000546 patent/WO1993018767A1/en active Application Filing
- 1993-03-10 AU AU36323/93A patent/AU3632393A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1993018767A1 (en) | 1993-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4199489A (en) | Composition for the treatment of erectile dysfunction | |
AU2176592A (en) | Methods of treating injury to the central nervous system | |
ZA938510B (en) | Use of alpha-1C specific compounds to treat denign prostatic hyperplasia | |
HUP9900065A3 (en) | Use of cgmp-phosphodiesterase inhibitors to treat impotence | |
AU7164987A (en) | Treatment of sexual dysfunction with buspirone | |
GB9608408D0 (en) | Treatment of erectile dysfunction | |
GB2266458B (en) | Use of 3-hydroxypyridin-4-ones as selective therapeutics | |
PH20062A (en) | Treatment of sexual dysfunction | |
EP1027057A4 (en) | Treatment of female sexual dysfunction | |
ZA933519B (en) | Treatment of wastewater | |
AU2160492A (en) | Treatment of human diseases involving dysregulation or dysfunction of the nervous system | |
AU3244693A (en) | Use of the combination of anti-tumor necrosis factor plus interleukin-6 to treat septic shock | |
AU3007492A (en) | Treatment of wastewater | |
AU3236093A (en) | The use of ob-101 to treat inflammation | |
TW236610B (en) | Preparation of dinitrotoluene | |
AU3235693A (en) | The use of ob-104 to treat inflammation | |
IL124841A0 (en) | Pge-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction | |
AU3234995A (en) | Use of il-6 to treat toxic shock | |
EP0413929A3 (en) | Use of an ace-inhibitor to treat or prevent depression | |
EP0543902A4 (en) | Use of metalloporphyrins to potentiate aids therapy | |
AU4704797A (en) | Use of benzopyranols to treat neurological disorders | |
AU3375093A (en) | Treatment of mineral tailings | |
GB2271579B (en) | Treatment of wood | |
AU3632393A (en) | Use of sydnonimines to treat erectile dysfunction | |
AU3477093A (en) | 17beta -hydroxybenzoyl-4-aza-5alpha-androst-1-en-3-ones useful to treat baldness |